Dr Abin Thomas

(e/fe)

2025

• Van Der Maas, N. G. et al. 2025. A revised prognostic model for patients with acute myeloid leukemia and first relapse. Blood Advances 9(15), pp. 3853-3864. (10.1182/bloodadvances.2025015797)
• Potter, N. et al. 2025. Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trials. The Lancet Haematology 12(5), pp. e346-e356. (10.1016/S2352-3026(25)00037-7)
• Russell, N. H., Thomas, A. and Freeman, S. D. 2025. Reply to: Treatment intensification based on residual disease in elderly patients with AML. Journal of Clinical Oncology (10.1200/JCO-25-00198)
• Aleem, A. et al. 2025. Discontinuation of tyrosine kinase inhibitor therapy and treatment free remission (TFR) in chronic myeloid leukemia: Successful achievement of TFR in more than two-third of patients in a real-world practice. Clinical Lymphoma, Myeloma and Leukemia 25(1), pp. 50-56. (10.1016/j.clml.2024.08.006)

2024

• Versluis, J. et al. 2024. Risk stratification in older intensively treated patients with AML. Journal of Clinical Oncology 42(34), pp. 4084-4094. (10.1200/JCO.23.02631)
• Russell, N. H. et al. 2024. Treatment intensification with either fludarabine, AraC, G-CSF and idarubicin, or cladribine plus daunorubicin and AraC on the basis of residual disease status in older patients With AML: Results From the NCRI AML18 Trial. Journal of Clinical Oncology (10.1200/JCO.24.00259)

2023

• Freeman, S. D. et al. 2023. Fractionated versus single dose Gemtuzumab Ozogamicin with determinants of benefit in older AML: UK NCRI AML18 Trial. Blood 142(20), pp. 1697-1707. (10.1182/blood.2023020630)

2022

• Russell, N. H. et al. 2022. Outcomes of older patients aged 60 to 70 years undergoing reduced intensity transplant for acute myeloblastic leukaemia: results of the NCRI acute myeloid leukemia 16 trial. Haematologica 107(7), pp. 1518-1527. (10.3324/haematol.2021.279010)

2021

• Tiong, I. S. et al. 2021. Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia. Blood Advances 5(23), pp. 5107-5111. (10.1182/bloodadvances.2021005455)
• Yousef, C. C. et al. 2021. Liraglutide effects on glycemic control and weight in patients with Type 2 Diabetes mellitus: a real-world, observational study and brief narrative review. Diabetes Research and Clinical Practice 177, article number: 108871. (10.1016/j.diabres.2021.108871)
• Nagraj, S., Karia, R., Hassanain, S., Ghosh, P., Shah, V. R. and Thomas, A. 2021. Role of invasive mechanical ventilation and ECMO in the management of COVID-19: a systematic review. Indian Journal of Critical Care Medicine 25(6), pp. 691-698. (10.5005/jp-journals-10071-23870)
• AlAmmari, M., Sultana, K., Alturaiki, A., Thomas, A., AlBabtain, M., AlAyoubi, F. and Richi, H. 2021. The development and validation of a multivariable model to predict the bleeding risk score for patients with non-valvular atrial fibrillation using direct oral anticoagulants in the Arab population.. PLoS ONE 16(5), article number: e0250502. (10.1371/journal.pone.0250502)
• Esba, L. C. A., Alqahtani, R. A., Thomas, A., Shamas, N., Alswaidan, L. and Mardawi, G. 2021. Ibuprofen and NSAID use in COVID-19 infected patients is not associated with worse outcomes: a prospective cohort sudy. Infectious Diseases and Therapy 10, pp. 253-268. (10.1007/s40121-020-00363-w)
• Ammari, M. A., Sultana, K., Thomas, A., Swaidan, L. A. and Harthi, N. A. 2021. Mental health outcomes amongst health care workers during COVID 19 pandemic in Saudi Arabia. Frontiers in Psychiatry 11, article number: 619540. (10.3389/fpsyt.2020.619540)

2020

• Tiong, I. S. et al. 2020. The natural history of NPM1MUT Measurable Residual Disease (MRD) positivity after completion of chemotherapy in Acute Myeloid Leukemia (AML). Presented at: 62nd American Society of Hematology Annual Meeting & Exposition (ASH 2020), Virtual, 5-8 December 2020, Vol. 136. Vol. Supple. American Society of Hematology pp. 25-27., (10.1182/blood-2020-140296)
• Yousef, C. C. et al. 2020. Adoption of a personal health record in the digital age: Cross-sectional study. Journal of Medical Internet Research 22(10), article number: e22913. (10.2196/22913)

2019

• Alaskar, A. et al. 2019. Chemotherapy effect on fertility in male patients with Hodgkin and Non-Hodgkin Lymphoma. Presented at: 61st American Society of Hematology Annual Meeting & Exposition (ASH 2019), Orlando, FL, USA, 07-10 December 2019, Vol. 134. Vol. Supple. American Society of Hematology pp. 5865., (10.1182/blood-2019-126447)
• Shaheeen, N. A., Manezhi, B., Thomas, A. and AlKelya, M. 2019. Reducing defects in the datasets of clinical research studies: conformance with data quality metrics. BMC Medical Research Methodology 19, article number: 98. (10.1186/s12874-019-0735-7)
• Alotaibi, B. et al. 2019. Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 Hajj. PLoS ONE 14(1), article number: e0210913. (10.1371/journal.pone.0210913)
• Shaheen, N. A., AlAtiq, Y., Thomas, A., Alanazi, H. A., AlZahrani, Z. E., Younis, S. A. R. and Hussein, M. A. 2019. Paternal postnatal depression among fathers of newborn in Saudi Arabia. American Journal of Men's Health 13(1), pp. 1-12. (10.1177/1557988319831219)